Global Disease Control And Prevention Overview
Disease control and prevention vaccines are the biological preparation which helps to provide active acquired immunity for a particular disease. Vaccines contains the agents which are same as the disease causing agents or often made up of killed or weak form of microbe, is protein or its toxins. These vaccines are widely used in prevention and control of wide range of infectious disease, and cancers.
The launches and approval of novel vaccines indicated for the treatment of various diseases is expected to drive the market growth over forecast period. For instance, in 2017, GlaxoSmithKline plc received U.S. Food and Drug Administration (FDA) approval for its new vaccine namely Shingrix (Zoster Vaccine Recombinant, Adjuvanted) indicated for the prevention of shingles (herpes zoster) in adults aged 50 years and older. Robust pipeline of vaccines for different disease which will to get approval in near future is expected to drastically drive the market growth.
Furthermore, the initiatives taken by various private and government organizations to increase access of vaccines among population are also expected to cater the growth of disease control and prevention vaccine market. For instance, in January 2018, Government of Uganda has launched a new rotavirus vaccine to protect under five-year-old children from diarrhea. The newly launched vaccines are available for free in health facilities throughout the country.
The disease control and prevention vaccine market has been segmented on the basis of vaccine type, product type, age group, indication and region.
The vaccine type segment includes Monovalent Vaccine and Multivalent Vaccine.
On the basis of product type the disease control and prevention vaccine market has been segmented in, live-attenuated vaccines, inactivated vaccines, recombinant vaccines, and toxoid vaccines.
On the basis of age group, disease control and prevention vaccine market has been segmented in pediatric and adults.
On the basis of application, the disease control and prevention vaccine market has been segmented in infectious disease, cancer, and other indication.
On the basis of region, the target market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East, and Africa. North America is expected to account major market share as compared to that of other regions.
Key players operating in the disease control and prevention vaccine market includes, AstraZeneca PLC, Sinovac Biotech Ltd., Astellas Pharma Inc., Serum Institute of India Pvt. Ltd., Daiichi Sankyo.GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., and Sanofi S.A.
Global Disease Control And Prevention Table of Contents
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Preview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Vaccine Type
- Market Snippet, By Product Type
- Market Snippet, By Age Group
- Market Snippet, By Application
- Market Snippet, By Region
- Opportunity Map Analysis
- Report Description
- Market Dynamics Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Drivers- Restraints Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Market Dynamics
- Market Segmentation, By Vaccine Type, 2018 – 2028, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Segment Trends
- Monovalent Vaccine
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Multivalent Vaccine
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Introduction
- Market Segmentation, By Product Type, 2018 – 2028, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Segment Trends
- Live-attenuated Vaccines
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Inactivated Vaccines
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Recombinant Vaccines
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Toxoid Vaccines
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Introduction
- Market Segmentation, By Age Group, 2018 – 2028, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Adults
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Introduction
- Market Segmentation, By Application, 2018 – 2028, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Segment Trends
- Infectious Disease
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Cancer
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Other Indication
- Introduction
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2018 – 2028
- Introduction
- Global Market, By Region, 2018 – 2028, (US$ Mn)
- Introduction
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2018 — 2028
- Y-o-Y Growth Analysis (%), 2019 – 2028
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Vaccine Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Age Groups, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
- Introduction
U.S.
Canada
- Latin America
- Market Size and Forecast (US$ Mn), By Vaccine Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Age Groups, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
Brazil
Mexico
Argentina and Chile
- Rest of Latin America Europe
- Market Size and Forecast (US$ Mn), By Vaccine Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Age Groups, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
Germany
UK
France
Russia
Italy
Switzerland
Sweden
Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Vaccine Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Age Groups, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
China
India
Australia & New Zealand
Japan
South Korea
Rest of Asia Pacific
- Middle East
- Market Size and Forecast (US$ Mn), By Vaccine Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Age Groups, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
GCC
Israel
Saudi Arabia
UAE
Rest of Middle East
- Africa
- Market Size and Forecast (US$ Mn), By Vaccine Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Product Type, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Age Groups, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Application, 2018 – 2028
- Market Size and Forecast (US$ Mn), By Country, 2018 – 2028
North Africa
Central Africa
South Africa
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- AstraZenca Plc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Business Strategy Overview
- Sinovac Biotech Ltd.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Business Strategy Overview
- Astellas Pharma Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Business Strategy Overview
- Serum Institute of India Pvt. Ltd.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Business Strategy Overview
- Daiichi Sankyo.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Business Strategy Overview
- GlaxoSmithKline plc
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Business Strategy Overview
- Merck & Co., Inc.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Business Strategy Overview
- Pfizer Inc.,
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Business Strategy Overview
- Sanofi S.A.
Company Overview
Product Portfolio
Key Highlights
Financial Overview
Business Strategy Overview
- Analyst Views
- Section
- Research Methodology
- About Us
- Contact
FAQs
The disease control and prevention vaccine market has been segmented on the basis of vaccine type, product type, age group, indication and region.
The launches and approval of novel vaccines indicated for the treatment of various diseases is expected to drive the market growth over forecast period.
Lack of awareness might hampers the market
Key players operating in the disease control and prevention vaccine market includes, AstraZeneca PLC, Sinovac Biotech Ltd., Astellas Pharma Inc., Serum Institute of India Pvt. Ltd., Daiichi Sankyo, GlaxoSmithKline plc, Merck & Co., Inc., Pfizer Inc., and Sanofi S.A.
North America is expected to account major market share as compared to that of other regions.